Full PDF Version Available:
BAE Systems plc. (BA.L), Initiation Summary
NATO: Nations. Arms. Tailwinds. Orders.
Field | Detail |
Recommendation | BUY |
Entry Price | £23.30 |
Target Price | £30.55 base / £33.67 Iran case |
Upside | 31.1% base / 44.5% Iran case |
Market Cap | £69.86B |
WACC / Terminal growth | 7.47% / 3.5% |
Date | 18 Mar 2026 |
Analysts: Christopher Hwang, CFA (studiochick.net), Selina Wang, CFA, CA, Keith Yuk, CA
Investment Case
BAE is not just a beneficiary of rising defence budgets. It sits inside the exact domains those budgets are flowing into: combat air, submarines and frigates, armoured vehicles, munitions, electronic warfare, cyber, space electronics and through life sustainment. The three pillars below carry the thesis.
- Structural rearmament beneficiary. NATO’s 5% of GDP framework by 2035 (3.5% core defence, 1.5% resilience/cyber) lands directly on BAE’s platform and electronics businesses. It is exposed to both the hardware layer and the “connect and protect” layer around it.
- Backlog backed compounding. FY2025 order intake of £36.8bn against revenue of £30.7bn gives a book to bill above one. Backlog of £83.6bn (2.7x revenue) is government backed, sticky, and long duration. Base case revenue grows from £28.3bn (FY2025A) to £43.1bn (FY2030E), EBIT margin expands 200bps to 10.8%, and FCF rises from £2.2bn to £3.6bn.
- Multi region insulation. Revenue splits roughly US 44%, UK 27%, Europe 12%, MEA 10%, Australia 4%, APAC 2%. A delay in one budget cycle (UK, US, Gulf, AUKUS) rarely hits all regions at once.
Financial Summary (£m)
Metric | FY2025A | FY2026E | FY2028E | FY2030E |
Revenue | 28,336 | 30,630 | 37,803 | 43,147 |
EBIT margin | 8.8% | 9.8% | 10.0% | 10.8% |
Net profit | 2,151 | 2,157 | 2,730 | 3,379 |
Free cash flow | - | 2,199 | 2,950 | 3,622 |
FCF margin | - | 7.2% | 7.8% | 8.4% |
Valuation
- DCF: £89.3bn enterprise value, £91.6bn equity value, £30.55 per share (base case).
- Relative check: BAE trades at 1.86x 2026E EV/Sales and 13.66x 2026E EV/EBITDA, both below the peer median of 2.06x and 14.47x. The DCF premium is not multiple driven; it is duration and backlog driven.
- Sensitivity: base case range £27.66 to £34.28 (3.0% to 4.0% terminal growth); Iran upside range £30.44 to £37.83.
Segment Mix (FY2025)
Segment | % of Revenue | Operating Margin |
Electronic Systems | 26.5% | 15.4% |
Air | 26.0% | 11.9% |
Maritime | 23.2% | 6.7% |
Platforms & Services | 17.7% | 11.4% |
Cyber & Intelligence | 8.5% | 9.3% |
Electronic Systems and Air carry the best economics and the strongest backlog momentum. Maritime is priced as entry pricing into decades of sovereign infrastructure (Dreadnought, Type 26, AUKUS), not as weak execution.
Top Risks
- Backlog conversion risk. Backlog is not revenue. Fixed price programmes can leak margin if labour and supply chains tighten.
- Budget timing risk. US continuing resolutions or European fiscal slippage could delay the conversion of pledges into funded procurement.
- Geopolitical de-escalation. A Ukraine settlement or Gulf de-escalation could compress sector multiples even if BAE’s own backlog holds.
- Software-defined disruption. Anduril, Palantir and similar players threaten margin in the highest value digital and autonomy layer.
Top Catalysts
- Quarterly earnings and book to bill showing margin-led, not just FX-led, beats.
- UK defence budget moving from pledge to funded procurement lines (path to 3% of GDP by 2029).
- GCAP/Tempest and AUKUS submarine milestones extending backlog duration into the 2050s.
- NATO members posting funded commitments above 3% of GDP.
SWOT Snapshot
Strengths: Tier-1 multi domain coverage, record £83.6bn backlog, strong US footprint via BAE Systems Inc.
Weaknesses: government dependency, labour and semiconductor supply constraints, fixed price execution risk.
Opportunities: new geographies, adjacent commercial aerospace and security.
Threats: peer competition (Rheinmetall, Saab, Thales), autonomous/AI-enabled disruption, sudden de-escalation.
Full initiation report with detailed thesis, industry analysis, segment breakdowns, pricing strategy, competitor benchmarking and risk/catalyst tables: see the long-form version.
Academic and educational purposes only. Not investment advice. Author holds no position in the securities discussed.